Literature DB >> 22621922

Vaccinia-related kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage.

Marta Sanz-García1, Diana M Monsalve, Ana Sevilla, Pedro A Lazo.   

Abstract

Cellular responses to DNA damage require the formation of protein complexes in a highly organized fashion. The complete molecular components that participate in the sequential signaling response to DNA damage remain unknown. Here we demonstrate that vaccinia-related kinase 1 (VRK1) in resting cells plays an important role in the formation of ionizing radiation-induced foci that assemble on the 53BP1 scaffold protein during the DNA damage response. The kinase VRK1 is activated by DNA double strand breaks induced by ionizing radiation (IR) and specifically phosphorylates 53BP1 in serum-starved cells. VRK1 knockdown resulted in the defective formation of 53BP1 foci in response to IR both in number and size. This observed effect on 53BP1 foci is p53- and ataxia-telangiectasia mutated (ATM)-independent and can be rescued with VRK1 mutants resistant to siRNA. VRK1 knockdown also prevented the activating phosphorylation of ATM, CHK2, and DNA-dependent protein kinase in response to IR. VRK1 activation in response to DNA damage is a novel and early step in the signaling of mammalian DNA damage responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22621922      PMCID: PMC3390650          DOI: 10.1074/jbc.M112.353102

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

1.  Molecular mechanism of the interaction between MDM2 and p53.

Authors:  Oliver Schon; Assaf Friedler; Mark Bycroft; Stefan M V Freund; Alan R Fersht
Journal:  J Mol Biol       Date:  2002-10-25       Impact factor: 5.469

2.  53BP1, a mediator of the DNA damage checkpoint.

Authors:  Bin Wang; Shuhei Matsuoka; Phillip B Carpenter; Stephen J Elledge
Journal:  Science       Date:  2002-10-03       Impact factor: 47.728

3.  PTIP regulates 53BP1 and SMC1 at the DNA damage sites.

Authors:  Jiaxue Wu; Marc J Prindle; Gregory R Dressler; Xiaochun Yu
Journal:  J Biol Chem       Date:  2009-05-04       Impact factor: 5.157

4.  Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells.

Authors:  Nozomi Tomimatsu; Bipasha Mukherjee; Sandeep Burma
Journal:  EMBO Rep       Date:  2009-05-15       Impact factor: 8.807

5.  Phosphorylation site interdependence of human p53 post-translational modifications in response to stress.

Authors:  Shin'ichi Saito; Hiroshi Yamaguchi; Yuichiro Higashimoto; Connie Chao; Yang Xu; Albert J Fornace; Ettore Appella; Carl W Anderson
Journal:  J Biol Chem       Date:  2003-07-14       Impact factor: 5.157

6.  DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1.

Authors:  Oscar Fernandez-Capetillo; Hua-Tang Chen; Arkady Celeste; Irene Ward; Peter J Romanienko; Julio C Morales; Kazuhito Naka; Zhenfang Xia; R Daniel Camerini-Otero; Noboru Motoyama; Phillip B Carpenter; William M Bonner; Junjie Chen; André Nussenzweig
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

7.  53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer.

Authors:  Richard A DiTullio; Tamara A Mochan; Monica Venere; Jirina Bartkova; Maxwell Sehested; Jiri Bartek; Thanos D Halazonetis
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

8.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Nature       Date:  2003-01-30       Impact factor: 49.962

Review 9.  Emerging biological functions of the vaccinia-related kinase (VRK) family.

Authors:  E P F Klerkx; P A Lazo; P Askjaer
Journal:  Histol Histopathol       Date:  2009-06       Impact factor: 2.303

10.  Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2.

Authors:  D P Teufel; M Bycroft; A R Fersht
Journal:  Oncogene       Date:  2009-04-13       Impact factor: 9.867

View more
  31 in total

Review 1.  Diverse cellular functions of barrier-to-autointegration factor and its roles in disease.

Authors:  Rhiannon M Sears; Kyle J Roux
Journal:  J Cell Sci       Date:  2020-08-17       Impact factor: 5.285

2.  Sensitivity of the kinase activity of human vaccinia-related kinase proteins to toxic metals.

Authors:  Iria Barcia-Sanjurjo; Marta Vázquez-Cedeira; Ramiro Barcia; Pedro A Lazo
Journal:  J Biol Inorg Chem       Date:  2013-03-13       Impact factor: 3.862

3.  Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase.

Authors:  Alexandria C Linville; Amber B Rico; Helena Teague; Lucy E Binsted; Geoffrey L Smith; Jonas D Albarnaz; Matthew S Wiebe
Journal:  J Virol       Date:  2022-05-11       Impact factor: 6.549

4.  Multivalent DNA and nucleosome acidic patch interactions specify VRK1 mitotic localization and activity.

Authors:  Gabrielle R Budziszewski; Yani Zhao; Cathy J Spangler; Katarzyna M Kedziora; Michael R Williams; Dalal N Azzam; Aleksandra Skrajna; Yuka Koyama; Andrew P Cesmat; Holly C Simmons; Eyla C Arteaga; Joshua D Strauss; Dmitri Kireev; Robert K McGinty
Journal:  Nucleic Acids Res       Date:  2022-05-06       Impact factor: 19.160

5.  VRK1 regulates Cajal body dynamics and protects coilin from proteasomal degradation in cell cycle.

Authors:  Lara Cantarero; Marta Sanz-García; Hadar Vinograd-Byk; Paul Renbaum; Ephrat Levy-Lahad; Pedro A Lazo
Journal:  Sci Rep       Date:  2015-06-12       Impact factor: 4.379

6.  VRK2 identifies a subgroup of primary high-grade astrocytomas with a better prognosis.

Authors:  Irene Rodríguez-Hernández; Marta Vázquez-Cedeira; Angel Santos-Briz; Juan L García; Isabel F Fernández; Juan A Gómez-Moreta; Javier Martin-Vallejo; Rogelio González-Sarmiento; Pedro A Lazo
Journal:  BMC Clin Pathol       Date:  2013-10-01

7.  DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells.

Authors:  Rebeca Carrión-Marchante; Valerio Frezza; Ana Salgado-Figueroa; M Isabel Pérez-Morgado; M Elena Martín; Víctor M González
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-17

8.  Ursolic acid exerts anti-cancer activity by suppressing vaccinia-related kinase 1-mediated damage repair in lung cancer cells.

Authors:  Seong-Hoon Kim; Hye Guk Ryu; Juhyun Lee; Joon Shin; Amaravadhi Harikishore; Hoe-Yune Jung; Hoe-Youn Jung; Ye Seul Kim; Ha-Na Lyu; Eunji Oh; Nam-In Baek; Kwan-Yong Choi; Ho Sup Yoon; Kyong-Tai Kim
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

9.  Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression.

Authors:  D M Monsalve; T Merced; I F Fernández; S Blanco; M Vázquez-Cedeira; P A Lazo
Journal:  Cell Death Dis       Date:  2013-02-28       Impact factor: 8.469

10.  Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response.

Authors:  Marcella Salzano; Marta Vázquez-Cedeira; Marta Sanz-García; Alberto Valbuena; Sandra Blanco; Isabel F Fernández; Pedro A Lazo
Journal:  Oncotarget       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.